FDA — authorised 3 October 2013
- Application: NDA022247
- Marketing authorisation holder: WYETH PHARMS
- Local brand name: DUAVEE
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 Bazedoxifene/Conjugated Estrogen in United States
FDA authorised Bazedoxifene/Conjugated Estrogen on 3 October 2013
Marketing authorisation
Other Women's Health / Endocrinology approved in United States
Frequently asked questions
Is Bazedoxifene/Conjugated Estrogen approved in United States?
Yes. FDA authorised it on 3 October 2013.
Who is the marketing authorisation holder for Bazedoxifene/Conjugated Estrogen in United States?
WYETH PHARMS holds the US marketing authorisation.